ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MTFB Motif Bio Plc

0.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.50 0.40 0.55 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Motif Bio Share Discussion Threads

Showing 9326 to 9345 of 9925 messages
Chat Pages: Latest  385  384  383  382  381  380  379  378  377  376  375  374  Older
DateSubjectAuthorDiscuss
24/4/2021
10:53
The delusion is real...taking about “yeah but we don’t know the opening price yet”

You have been diluted to oblivion so you don’t need to worry about the price - the damage is done

When Iclaprim was taken out of the deal here - that was the last line of defence for LTH in Motif - oblivion awaits here

scottdavid70
24/4/2021
10:50
Just by BOU who Robblertwo has been promoting as a case study for RTO’s - appropriate consolidation looks like 500-1 here....how’s that feeling for everyone along with a fundraise?

Remember when Lumsden kept you locked in with no clinical trials when the price was fluctuating around 9p and then all bases covered at 4p?

How’s that all sitting in the throat right now?

More annoyed by my posts highlighting what’s gone on here?

scottdavid70
24/4/2021
10:35
If anyone in the group of companies ‘helping’; Motif Bio and the Board of Directors had a conscience and a sense of right or wrong then they would definitely advise and Graham Lumsdne should take ownership of the grotesquely greedy bonus and relinquish it with immediate effect. It would show that they have a modicum of understanding between right and wrong. What they have done to shareholders investments whilst supposedly acting in their best interests.

Jonathan Gold would also come out and say that he has been working for free since failing to get the RTO done by the end of January as it was supposed to be done.

Investors have taken all the risk and the Directors are under rules committing them to act in shareholders best interests.

Clearly paying more money to Directors for missing deadlines, thereby indirectly incentivising them to actually miss deadlines and bonuses to Directors who have caused cataclysmic wealth destruction isn’t in shareholders best interests.

scottdavid70
23/4/2021
22:56
Not one person on here on LSE disputed this was now the most likely reason and outcome as to why Orange Avenue Technologies LLC was set up

Courtesy of DavidUncle on LSE

“Orange Avenue Technologies LLC

As I understand it - this was set up now to take Iclaprim out of Motif Bio so that when the RTO doesn't happen or potentially doesn't happen they can still profit
from it hence the secrecy surrounding anything to do with this company bar knowing John Palmer owns it.

That makes a lot of sense if true. They have ringed fenced the asset for themselves. Until we hear otherwise this hypothesis is the one I tend to now agree with”

Lemmings and lambs to the slaughter

scottdavid70
23/4/2021
10:42
Not true Chuffer actually but I do agree things are very bleak here now and things have been done to keep upside for the Board in the future with the only man who couldn’t sell Iclaprim over 18 months still holding the keys to the asset.

How else do you explain it.

scottdavid70
23/4/2021
10:23
Courtesy of DavidUncle on LSE

“Orange Avenue Technologies LLC

As I understand it - this was set up now to take Iclaprim out of Motif Bio so that when the RTO doesn't happen or potentially doesn't happen they can still profit
from it hence the secrecy surrounding anything to do with this company bar knowing John Palmer owns it.

That makes a lot of sense if true. They have ringed fenced the asset for themselves. Until we hear otherwise this hypothesis is the one I tend to now agree with”

scottdavid70
23/4/2021
10:18
Interesting post this morning on LSE about Orange Avenue Technologies LLC- might make the most sense of what undoubtedly was a very weird development

As I have said the audit in my humble opinion is a massive red herring- bigger than Tony Blair’s weapons of mass destruction

scottdavid70
22/4/2021
20:39
Remember the RTO was touted originally as due to the potential created by COViD - remember that RNS? Covid they said but funnily enough it’s got nothing to do with Covid

Laughable stuff every time from this Board of Clowns

scottdavid70
22/4/2021
19:15
No one that has been invested here since anytime from 2019 and any poor soils invested before then - well I feel for you but you know the drill - zero chance given Motifs history or Graham Lumsdens of an RNS announcement being in April
scottdavid70
22/4/2021
18:52
I have had more marketing today from the Jehovah’s Witnesses and Woolworths today than any miraculous RTO at Motif Bio

Had more information on the benefits of eating kale than a multi billion dollar antibiotic

Woolworths I found out has been busy for over a year as well!!

scottdavid70
22/4/2021
17:56
Tomorrow's the end of April??
small crow
22/4/2021
17:36
Well it's tomorrow or there must be some more paperwork to finish lol
tnt99
22/4/2021
06:37
RNS - 29 Mar 21"As such, should the Proposed Transaction proceed, it is expected that Motif will now publish the AIM Admission Document in late April or early May 2021.At present there can be no assurances that Motif will be able to complete the Proposed Transaction and as a consequence the Company's admission to trading on AIM may be cancelled."Not much longer to wait. Fingers crossed for a positive outcome.
lithological heterogeneities
21/4/2021
20:23
Don’t forget to am appropriate level of consolidation in your shares means nothing to those making that decision. They haven’t bought any with their money - doesn’t hurt them at

Easy for them to obliterate your holding

scottdavid70
21/4/2021
20:01
If Carlsberg did marketing like Motif Bio their beer would still be popular

Lumsden and Gold showing Saatchi and Saatchi how to do it. Feel like I am watching the Super Bowl half time ads with the publicity for Motifs RTO and Iclaprim sale. Wow

scottdavid70
21/4/2021
10:59
Do we think BIOMARCK shareholders knew that Graham Lumsden didn’t do a Corporate Governance review in 2019?

Had he done so on the back of a terrible and disastrous year at the helm of Motif Bio would he have been hired?

That review could have been crucial

scottdavid70
21/4/2021
10:55
Motif Bio were needing Warren Buffett and sadly got Little Miss Moffat
scottdavid70
21/4/2021
10:01
Morning all ,,,, er, Scott.
small crow
21/4/2021
09:58
Just like tor owners of EPL clubs the owners aren’t as powerful as they think they are - same here - collective pressure from shareholders means accountability for shareholders from Directors.

Don’t lose sight of what you can all achieve if you act your rather individuals

scottdavid70
21/4/2021
07:31
Motif Bio - Walbrook PR (you would think being PR they would know better) and Jonathan Gold and Graham Lumsden haven’t quite worked out this marketing and advertising thing have they?

Zero on the RTO and zero on Iclaprim publicly apart from a pre-school 2 pager A4 on John Palmer’s LinkedIn page.

For the millions they have snaffled in investors cash for themselves you think they could have spent a few bob on getting the story out there

scottdavid70
Chat Pages: Latest  385  384  383  382  381  380  379  378  377  376  375  374  Older

Your Recent History

Delayed Upgrade Clock